Skip to main content
SLS logo

SLS · SELLAS Life Sciences Group, Inc.

Track SLS — free
$13.86 +0.16 (+1.17%) At close · Sep 4
Market Cap
$2.80B
Shares
201.95M

Debt Profile

Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.

Debt data is being processed. Please check back later.
Key facts CIK 1390478 CUSIP 81642T209 13F (30d) 121 filings 121 filers Visit website Investor relations